These findings strongly support a role for IL-10-secreting B-cells in limiting infarct volume after stroke, reducing mortality, inhibiting inflammatory cell recruitment, and ameliorating functional neurologic injury, suggesting that regulatory B-cell enhancement may serve as a novel therapy for this severe neuropathic state (Ren et al., 2011a). The gene discussed is IL10; the disease is stroke disorder.